- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.95 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x GOL: GLYCEROL(Non-functional Binders)
GOL.2: 13 residues within 4Å:- Chain A: T.33, L.35, V.108, L.109, G.110, D.111
- Chain C: T.33, L.35, V.108, L.109, G.110, D.111
- Ligands: GOL.11
6 PLIP interactions:4 interactions with chain A, 2 interactions with chain C- Hydrogen bonds: A:V.108, A:G.110, A:D.111, A:D.111, C:G.110, C:D.111
GOL.7: 11 residues within 4Å:- Chain B: K.23, V.31, G.32, T.33, H.44
- Chain D: K.23, V.31, G.32, T.33, H.44
- Ligands: GOL.16
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:G.32, B:H.44
GOL.11: 13 residues within 4Å:- Chain A: T.33, L.35, V.108, L.109, G.110, D.111
- Chain C: T.33, L.35, V.108, L.109, G.110, D.111
- Ligands: GOL.2
6 PLIP interactions:4 interactions with chain A, 2 interactions with chain C- Hydrogen bonds: A:V.108, A:G.110, A:D.111, A:D.111, C:G.110, C:D.111
GOL.16: 11 residues within 4Å:- Chain B: K.23, V.31, G.32, T.33, H.44
- Chain D: K.23, V.31, G.32, T.33, H.44
- Ligands: GOL.7
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:G.32, B:H.44
- 4 x ZRN: (2R,3S)-3-[(2S)-2-amino-4,4-diethyl-6-oxo-1,3-diazinan-1-yl]-N-[(1R,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2-(methoxymethyl)-2-methyl-2,3-dihydro-1-benzofuran-5-carboxamide(Non-covalent)
ZRN.3: 45 residues within 4Å:- Chain A: S.28, Q.29, I.46, D.48, G.50, S.51, I.91, F.93, S.95, I.135, F.136, I.139, F.141, I.144, Y.212, D.238, G.240, T.241, M.307, I.309, V.311, L.320
- Chain C: S.28, Q.29, I.46, D.48, G.50, S.51, I.91, F.93, S.95, I.135, F.136, I.139, F.141, I.144, Y.212, D.238, G.240, T.241, M.307, I.309, V.311, L.320
- Ligands: ZRN.12
23 PLIP interactions:5 interactions with chain C, 18 interactions with chain A- Hydrogen bonds: C:S.28, A:S.28, A:G.50, A:G.240, A:G.240
- Water bridges: C:S.242, C:S.242, A:S.242, A:S.242
- Salt bridges: C:D.48, C:D.238, A:D.48, A:D.238
- Hydrophobic interactions: A:Q.29, A:I.46, A:S.51, A:F.93, A:I.135, A:I.139, A:F.141, A:I.144, A:M.307, A:L.320
ZRN.8: 41 residues within 4Å:- Chain B: S.28, Q.29, I.46, D.48, G.50, S.51, I.91, F.93, S.95, I.135, F.136, I.139, F.141, I.144, Y.212, D.238, G.240, T.241, I.309, L.320
- Chain D: S.28, Q.29, I.46, D.48, G.50, S.51, I.91, F.93, S.95, I.135, F.136, I.139, F.141, I.144, Y.212, D.238, G.240, T.241, I.309, L.320
- Ligands: ZRN.17
22 PLIP interactions:15 interactions with chain B, 7 interactions with chain D- Hydrophobic interactions: B:Q.29, B:I.46, B:F.93, B:I.135, B:I.139, B:F.141, B:L.320
- Hydrogen bonds: B:S.28, B:S.28, B:G.50, B:G.50, B:S.95, B:G.240, D:S.28
- Salt bridges: B:D.48, B:D.238, D:D.48, D:D.238
- Water bridges: D:S.242, D:S.242, D:S.242, D:S.242
ZRN.12: 45 residues within 4Å:- Chain A: S.28, Q.29, I.46, D.48, G.50, S.51, I.91, F.93, S.95, I.135, F.136, I.139, F.141, I.144, Y.212, D.238, G.240, T.241, M.307, I.309, V.311, L.320
- Chain C: S.28, Q.29, I.46, D.48, G.50, S.51, I.91, F.93, S.95, I.135, F.136, I.139, F.141, I.144, Y.212, D.238, G.240, T.241, M.307, I.309, V.311, L.320
- Ligands: ZRN.3
23 PLIP interactions:5 interactions with chain C, 18 interactions with chain A- Hydrogen bonds: C:S.28, A:S.28, A:G.50, A:G.240, A:G.240
- Water bridges: C:S.242, C:S.242, A:S.242, A:S.242
- Salt bridges: C:D.48, C:D.238, A:D.48, A:D.238
- Hydrophobic interactions: A:Q.29, A:I.46, A:S.51, A:F.93, A:I.135, A:I.139, A:F.141, A:I.144, A:M.307, A:L.320
ZRN.17: 41 residues within 4Å:- Chain B: S.28, Q.29, I.46, D.48, G.50, S.51, I.91, F.93, S.95, I.135, F.136, I.139, F.141, I.144, Y.212, D.238, G.240, T.241, I.309, L.320
- Chain D: S.28, Q.29, I.46, D.48, G.50, S.51, I.91, F.93, S.95, I.135, F.136, I.139, F.141, I.144, Y.212, D.238, G.240, T.241, I.309, L.320
- Ligands: ZRN.8
22 PLIP interactions:15 interactions with chain B, 7 interactions with chain D- Hydrophobic interactions: B:Q.29, B:I.46, B:F.93, B:I.135, B:I.139, B:F.141, B:L.320
- Hydrogen bonds: B:S.28, B:S.28, B:G.50, B:G.50, B:S.95, B:G.240, D:S.28
- Salt bridges: B:D.48, B:D.238, D:D.48, D:D.238
- Water bridges: D:S.242, D:S.242, D:S.242, D:S.242
- 6 x SO4: SULFATE ION(Non-functional Binders)
SO4.4: 7 residues within 4Å:- Chain A: K.23, L.25, R.26
- Chain C: K.23, L.25, R.26
- Ligands: SO4.13
5 PLIP interactions:2 interactions with chain C, 3 interactions with chain A- Salt bridges: C:K.23, C:R.26, A:K.23, A:R.26
- Hydrogen bonds: A:R.26
SO4.5: 3 residues within 4Å:- Chain A: R.81
- Chain C: R.81
- Ligands: SO4.14
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain A- Salt bridges: C:R.81, A:R.81
SO4.9: 7 residues within 4Å:- Chain B: K.23, L.25, R.26
- Chain D: K.23, L.25, R.26
- Ligands: SO4.18
6 PLIP interactions:3 interactions with chain B, 3 interactions with chain D- Hydrogen bonds: B:R.26, D:R.26
- Salt bridges: B:K.23, B:R.26, D:K.23, D:R.26
SO4.13: 7 residues within 4Å:- Chain A: K.23, L.25, R.26
- Chain C: K.23, L.25, R.26
- Ligands: SO4.4
5 PLIP interactions:2 interactions with chain C, 3 interactions with chain A- Salt bridges: C:K.23, C:R.26, A:K.23, A:R.26
- Hydrogen bonds: A:R.26
SO4.14: 3 residues within 4Å:- Chain A: R.81
- Chain C: R.81
- Ligands: SO4.5
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain A- Salt bridges: C:R.81, A:R.81
SO4.18: 7 residues within 4Å:- Chain B: K.23, L.25, R.26
- Chain D: K.23, L.25, R.26
- Ligands: SO4.9
6 PLIP interactions:3 interactions with chain B, 3 interactions with chain D- Hydrogen bonds: B:R.26, D:R.26
- Salt bridges: B:K.23, B:R.26, D:K.23, D:R.26
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.6: 5 residues within 4Å:- Chain B: K.104, N.116
- Chain D: K.104, N.116
- Ligands: NAG.15
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain D- Hydrogen bonds: B:K.104, B:N.116, D:K.104
NAG.15: 5 residues within 4Å:- Chain B: K.104, N.116
- Chain D: K.104, N.116
- Ligands: NAG.6
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain D- Hydrogen bonds: B:K.104, B:N.116, D:K.104
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hodder, A.N. et al., Plasmodium vivax PMX-MK7602 inhibitor complex. To Be Published
- Release Date
- 2025-02-26
- Peptides
- Aspartyl protease, putative: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.95 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x GOL: GLYCEROL(Non-functional Binders)
- 4 x ZRN: (2R,3S)-3-[(2S)-2-amino-4,4-diethyl-6-oxo-1,3-diazinan-1-yl]-N-[(1R,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2-(methoxymethyl)-2-methyl-2,3-dihydro-1-benzofuran-5-carboxamide(Non-covalent)
- 6 x SO4: SULFATE ION(Non-functional Binders)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hodder, A.N. et al., Plasmodium vivax PMX-MK7602 inhibitor complex. To Be Published
- Release Date
- 2025-02-26
- Peptides
- Aspartyl protease, putative: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B